The National Health Service (NHS) is deploying an artificial intelligence (AI) triage tool within its official app to direct patients to appropriate care services. This initiative, part of a £10bn package to overhaul NHS systems, will reach about 200,000 patients in England over the next year.
The tool will be used to triage patients and to ascertain if they should be allocated a GP appointment. Depending on the severity of their condition, some may be advised to attend a pharmacy or their local A&E department instead.
In Plain English: The Clinical Takeaway
- Digital Sorting: The app acts as a digital filter, deciding if you need a doctor, a pharmacist, or emergency care based on your symptoms.
- Faster Routing: The goal is to determine if patients should be allocated a GP appointment or directed elsewhere.
- Phased Rollout: This isn’t happening everywhere at once; about 200,000 people in England will be reached over the coming year.
How the AI Triage Algorithm Determines Patient Pathways
The tool functions to triage patients and ascertain if they should be allocated a GP appointment. Depending on the severity of the condition, it may direct the user to A&E or suggest a pharmacy visit.
| Patient Symptom Severity | AI-Directed Pathway | Objective Goal |
|---|---|---|
| High Severity | A&E / Emergency Services | Appropriate Care |
| Requires GP | GP Appointment | Appropriate Care |
| Lower Severity | Community Pharmacy | Appropriate Care |
Funding, Transparency, and the £10bn Overhaul
The integration of AI triage is part of a £10bn package to overhaul NHS systems.
Contraindications & When to Consult a Doctor
AI triage is a supportive tool. Patients should seek medical intervention based on the severity of their condition.
The Future of Patient Access in England
The tool will be used to direct patients to the appropriate services. As the tool reaches about 200,000 patients over the next year, the NHS will utilize this as part of the £10bn investment to overhaul systems.
References
- World Health Organization (WHO)
- U.S. Food and Drug Administration (FDA)
- The Lancet
- PubMed Central (PMC)
